|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
43,990,000 |
Market
Cap: |
631.26(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$12.17 - $24.61 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
57,878 |
180,115 |
180,115 |
210,533 |
Total Sell Value |
$1,203,255 |
$3,323,210 |
$3,323,210 |
$4,306,417 |
Total People Sold |
2 |
2 |
2 |
3 |
Total Sell Transactions |
4 |
8 |
8 |
15 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fmr Corp |
See Remark 1 |
|
2016-05-10 |
4 |
S |
$10.04 |
$110,318 |
I/I |
(10,943) |
674,606 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-05-09 |
4 |
S |
$9.88 |
$56,916 |
I/I |
(5,731) |
685,549 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-05-06 |
4 |
S |
$9.89 |
$48,171 |
I/I |
(4,839) |
691,280 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-05-04 |
4 |
S |
$10.42 |
$19,919 |
I/I |
(1,896) |
696,119 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-05-03 |
4 |
S |
$10.73 |
$39,219 |
I/I |
(3,650) |
698,015 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-05-02 |
4 |
S |
$10.66 |
$25,847 |
I/I |
(2,396) |
701,665 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-29 |
4 |
S |
$10.79 |
$51,020 |
I/I |
(4,723) |
704,061 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-28 |
4 |
S |
$11.23 |
$56,025 |
I/I |
(4,918) |
708,784 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-27 |
4 |
S |
$11.14 |
$316,678 |
I/I |
(28,278) |
713,702 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-26 |
4 |
S |
$11.12 |
$58,936 |
I/I |
(5,300) |
741,980 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-25 |
4 |
S |
$11.29 |
$43,896 |
I/I |
(3,888) |
747,280 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-22 |
4 |
S |
$11.30 |
$196,145 |
I/I |
(17,358) |
751,168 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-21 |
4 |
S |
$11.28 |
$36,096 |
I/I |
(3,200) |
768,526 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-20 |
4 |
S |
$11.42 |
$47,964 |
I/I |
(4,200) |
771,726 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-19 |
4 |
S |
$11.77 |
$105,801 |
I/I |
(8,989) |
775,926 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-18 |
4 |
S |
$11.94 |
$114,624 |
I/I |
(9,600) |
784,915 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-15 |
4 |
S |
$11.56 |
$107,508 |
I/I |
(9,300) |
794,515 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-14 |
4 |
S |
$11.57 |
$54,772 |
I/I |
(4,734) |
803,815 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-13 |
4 |
S |
$11.44 |
$228,800 |
I/I |
(20,000) |
808,549 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-04-12 |
4 |
S |
$11.44 |
$26,335 |
I/I |
(2,302) |
828,549 |
|
- |
|
Fmr Corp |
See Remark 1 |
|
2016-03-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(254,965) |
830,851 |
|
- |
|
Fmr Corp |
10% Owner |
|
2015-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,085,816 |
|
- |
|
Mills Kenneth T. |
See Remarks |
|
2015-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
15,440 |
15,440 |
|
- |
|
Engleman Edgar |
Director |
|
2015-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
940,449 |
114,108 |
|
- |
|
Fox Allan M. |
Director |
|
2015-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,777,348 |
2,054,863 |
|
- |
|
406 Records found
|
|
Page 16 of 17 |
|
|